about
Nanobody-derived nanobiotechnology tool kits for diverse biomedical and biotechnology applicationsNanobodies as Versatile Tools to Understand, Diagnose, Visualize and Treat CancerDrug Delivery Approaches for the Treatment of Cervical CancerIn vivo detection of small tumour lesions by multi-pinhole SPECT applying a (99m)Tc-labelled nanobody targeting the Epidermal Growth Factor Receptor.Biomedical applications of glycosylphosphatidylinositol-anchored proteinsPhage display as a promising approach for vaccine developmentIdentification of a nanobody specific to human pulmonary surfactant protein A.Novel recombinant immunotoxin of EGFR specific nanobody fused with cucurmosin, construction and antitumor efficiency in vitro.Genetic Passive Immunization with Adenoviral Vector Expressing Chimeric Nanobody-Fc Molecules as Therapy for Genital Infection Caused by Mycoplasma hominis.High affinity nanobodies against human epidermal growth factor receptor selected on cells by E. coli display.Differentially expressed proteins in glioblastoma multiforme identified with a nanobody-based anti-proteome approach and confirmed by OncoFinder as possible tumor-class predictive biomarker candidates.Distinct antibody species: structural differences creating therapeutic opportunitiesAnalysis and Ranking of Protein-Protein Docking Models Using Inter-Residue Contacts and Inter-Molecular Contact Maps.99m Tc-anti-epidermal growth factor receptor nanobody for tumor imaging.Structurally Defined αMHC-II Nanobody-Drug Conjugates: A Therapeutic and Imaging System for B-Cell Lymphoma.The Emerging Role of Nanotechnology in Cell and Organ Transplantation.Recent progress in protein-protein interaction study for EGFR-targeted therapeutics.Recombinant Antibody Fragments for Neurodegenerative Diseases.111In- and IRDye800CW-Labeled PLA-PEG Nanoparticle for Imaging Prostate-Specific Membrane Antigen-Expressing Tissues.Sindbis Virus-Pseudotyped Lentiviral Vectors Carrying VEGFR2-Specific Nanobody for Potential Transductional Targeting of Tumor Vasculature.Enhanced Biosensor Platforms for Detecting the Atherosclerotic Biomarker VCAM1 Based on Bioconjugation with Uniformly Oriented VCAM1-Targeting Nanobodies.Legomedicine-A Versatile Chemo-Enzymatic Approach for the Preparation of Targeted Dual-Labeled Llama Antibody-Nanoparticle ConjugatesNanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics.Nanobodies As Novel Agents for Targeting Angiogenesis in Solid Cancers.Synthesis, Functionalization, and Design of Magnetic Nanoparticles for Theranostic Applications.Quantum-Dot-Based Theranostic Micelles Conjugated with an Anti-EGFR Nanobody for Triple-Negative Breast Cancer Therapy.Development of a novel nano-sized anti-VEGFA nanobody with enhanced physicochemical and pharmacokinetic properties.A toolbox of anti-mouse and anti-rabbit IgG secondary nanobodies.A cDNA Immunization Strategy to Generate Nanobodies against Membrane Proteins in Native Conformation.Application of Assisted Design of Antibody and Protein Therapeutics (ADAPT) improves efficacy of a Clostridium difficile toxin A single-domain antibody.Suppression of Breast Cancer Cell Proliferation by Selective Single-Domain Antibody for Intracellular STAT3.A Single Domain-Based Anti-Her2 Antibody Has Potent Antitumor Activities.Astatine-211 labeled anti-HER2 5F7 single domain antibody fragment conjugates: radiolabeling and preliminary evaluation.An efficient protocol towards site-specifically clickable nanobodies in high yield: cytoplasmic expression in Escherichia coli combined with intein-mediated protein ligation.Fluorine-18 Labeling of the HER2-Targeting Single-Domain Antibody 2Rs15d Using a Residualizing Label and Preclinical Evaluation.Single-Domain Antibodies and the Promise of Modular Targeting in Cancer Imaging and Treatment.A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells.Effective Delivery of Arsenic Trioxide to HPV-Positive Cervical Cancer Cells Using Optimised Liposomes: A Size and Charge Study.
P2860
Q26738678-25DD0551-9D7B-4FB4-89E5-7CBCF8E3F71AQ26739702-2FB01CCD-124D-46F0-BF2B-CA98EDAF0753Q26742026-D05BDE78-B7CD-4F08-9727-648EEE25A6C9Q27342927-D3B84548-5AF7-4D18-AE90-B6259C5279B0Q27468625-74908FCB-88C6-4C1A-86FD-D04FF1326273Q28074592-9D60E284-4C48-4E8A-BE39-F0B7051370EDQ33684637-ECF87B14-56A2-452C-BDF3-4D3D816A928CQ33888876-9331790C-47D0-438C-8A3B-5D5608E2F590Q35952105-C69D0CC3-B003-4450-9080-12D2D00621C7Q36089600-E855122B-B39A-4652-A169-7FFB3D12C4F3Q36370196-62D1FE3A-9073-4FA1-960B-16782A526327Q36945545-62372CCB-7C9E-4EDC-A9EC-445F739480B3Q38542405-A0F13186-4CB4-46F1-89BC-EDCFB99D61A7Q38744686-1A2E21D1-B82E-43BA-8280-6CE590E19A8CQ38797038-FF959470-BDC4-4B43-9A55-E6BFFD1435EEQ38852662-8A2F047C-AD09-43D4-845C-E09A1C353A37Q38899428-4C5DFC0B-C6FE-4B59-9CB3-430DB96BD901Q38970823-5AB416E1-E873-48DF-B1E7-3B1AE823BEAFQ39077979-16EE2BB3-E54C-4DD5-944A-437D409CED2BQ39372488-A60359DB-1C2C-460D-883D-7238A5C023F3Q39614361-3A15454A-D633-4101-88B4-9E94F0B17898Q42319260-13AC3B83-D87A-4ABE-8239-BC2CD38ABF6DQ47099672-20B8771B-7C0A-424C-A7A5-FE974DD432B0Q47134203-1BA94A33-28B9-4C9B-BA92-8C47DAE2E879Q47589446-E5584904-9E7E-493C-9E32-B47DCABFD699Q47748669-FE6B13A5-05B0-4690-A166-CBA3F2679209Q47753474-E42F71AC-6839-46D3-A583-32B8F0328288Q48374668-1A93898D-A32B-464F-9F9C-3BB936C30260Q48509449-77E33FD7-332B-4EDF-A57B-E8A6E99C96D9Q49357853-18FC1651-3F26-4222-8ACE-1615562419FAQ49582909-860A4097-F020-4458-A92B-185669AF5004Q49894096-52B870A6-029D-469E-A520-F16909738F12Q50068024-D6B12D70-CD4D-4CAA-9B05-EB435A787689Q51820924-B42C509F-E648-4337-BD84-1EE4B695ECE8Q52098663-87470A28-8AAE-4662-8AB4-FB3266A4B91EQ52362264-18331270-60F2-4D5F-AD13-582BC83E17E2Q52731753-0DF3854C-97AD-4F64-9F52-3468A532D60EQ55390533-BF1E4FA9-1890-46D9-BA38-BA784A65D97E
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Nanobody-based cancer therapy of solid tumors.
@en
type
label
Nanobody-based cancer therapy of solid tumors.
@en
prefLabel
Nanobody-based cancer therapy of solid tumors.
@en
P2093
P2860
P356
P1433
P1476
Nanobody-based cancer therapy of solid tumors.
@en
P2093
Bram Dorresteijn
Marta Kijanka
Paul M P van Bergen en Henegouwen
P2860
P304
P356
10.2217/NNM.14.178
P577
2015-01-01T00:00:00Z